Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Gilad Oren
President/CEO at Aprea Therapeutics. Filing since 13 Mar 2024.
CIK 0001929300
Company
Date
Role
Action
Shares
Amount
Of holding
APRE
Aprea Therapeutics, Inc.
30 Jan 2026
President/CEO
Bought
28,100
$25.01K
8.1%
APRE
Aprea Therapeutics, Inc.
3 Apr 2025
President/CEO
Bought
5,500
$10.11K
1.6%
APRE
Aprea Therapeutics, Inc.
23 Oct 2024
President/CEO
Bought
500
$1.96K
0.2%
APRE
Aprea Therapeutics, Inc.
15 Oct 2024
President/CEO
Bought
250
$725.00
0.1%
APRE
Aprea Therapeutics, Inc.
14 Oct 2024
President/CEO
Bought
1,000
$2.59K
0.3%
APRE
Aprea Therapeutics, Inc.
10 Oct 2024
President/CEO
Bought
150
$381.00
0.0%
APRE
Aprea Therapeutics, Inc.
13 Mar 2024
President, CEO
Bought
2,000
$14.58K
0.6%
7 decisions on file.